Print Options

Font size:

← Back to notecard set|Easy Notecards home page

To print: Ctrl+PPrint as notecards

Patho Exam 1

1.

Disease

deviation from normal structure or function of any part of the body or from a state of wellness

2.

Primary Prevention

Education on disease risk factors and prevent acquiring disease - don't develop the disease

3.

Secondary Prevention

goal to halt or slow progression of disease in early stages - after disease or serious risk factors for disease develop

4.

Tertiary Prevention

prevent further deterioration and improve quality of life - management of chronic health problems

5.

Diagnosis

identification of a specific disease through evaluation of signs, symptoms, lab tests, and other tools

6.

Etiology

causative factors in a particular disease - congenital defects, inherited disorders, microorganisms, immune dysfunction, metabolic derangements, environment, nutritional deficiencies

7.

Idiopathic

cause of disease is unknown

8.

Iatrogenic

disease caused by treatment, procedure, or error

9.

Predisposing factor

tendency to promote development of disease in an individual

10.

Prophylaxis

a measure/step designed to preserve health and prevent spread of disease

11.

Prevention

type of measure closely linked to etiology of disease

12.

Pathogenesis

development of disease; sequence of events of tissue changes

13.

Onset of disease

can be sudden, acute, or insidious (gradual progression)

14.

Duration

can be acute or chronic

15.

Subclinical

pathological changes, but few if any symptoms

16.

Latent

initial period with no symptoms; incubation period

17.

Prodromal

period of early disease development with non-specific symptoms (fatigue, HA, loss of appetite); lab tests negative

18.

Manifestations

signs and symptoms of disease; local at side of problem or systemic

19.

Signs

objective indicators of disease obvious to someone other than affected individuals

20.

Symptoms

subjective feelings, pain or nausea

21.

Lesion

specific local change in tissue; micro- or macroscopic

22.

Syndrome

collection of signs and symptoms often more than one organ that occur together in response to a certain condition

23.

Remission

period or condition where manifestations subside permanently or temporarily

24.

Exacerbation

worsening of disease manifestations

25.

Precipitating factor

a condition that triggers an acute episode

26.

Predisposing factor

an increased risk factor for a disease

27.

Complications

new, secondary, or additional problems that arise after original disease begins

28.

Therapy

measures of treatment used to promote recovery or slow the progression or disease

29.

Sequelae

potential unwanted outcomes of the primary condition

30.

Convalescence/rehabilitation

the period of recovery and return to the normal health state

31.

Prognosis

probability for recovery or other outcomes

32.

Morbidity

disease rates in a group; functional impairment that certain conditions cause in a population

33.

Mortality

relative number of deaths from a disease

34.

Autopsy

postmortem examination of all parts of the body after

35.

Epidemiology

science of tracking the pattern or occurrence of disease

36.

Incidence

number of new cases in a place in a set time period

37.

Prevalence

total number of new and old cases in a place in a set time period

38.

Endoscopic examination

visualize lesions or structures directly through a tube inserted in the body through opening or body wall

39.

Radiography/X-ray film

ionizing radiation, image on film of bones, soft tissue that vary in density. Plain, contrast, mammography, DXA

40.

Computed tomography (CT Scan)

360* x-rays in series of shots, formerly CAT scan

41.

Ultrasound

high frequency sound waves that bounce off body structures

doppler: assess blood flow

echocardiography: measures efficiency of heart valves and heart function

42.

Magnetic Resonance Imaging (MRI)

uses magnetic field surrounding body and the hydrogen (water) content of body; radio waves energy source; nonionizing.

can project past bone

43.

Nuclear Scanning

track distribution of a radioactive tracer substance in the body

44.

Positron Emission Tomography (PET)

radioisotopes w/ scanner and computer to produce a cross-sectional functional image of tissue

biochemical changes in the tissue

45.

Electrocardiogram (ECG/EKG)

assess conduction system of the heart

abnormal patterns assist with diagnosis of myocardial infarctions, cardiac dysrhythmias, electrolyte imbalances, digoxin toxicity

46.

Stress test (exercise ECG)

test cardiac function under increased workload

47.

Electroencephalogram (EEG)

electrical activity in the brain

abnormal patterns may indicate seizure disorders, tumors, or injuries

48.

Spirometry

measures lung volume and capacities

deviations from normal can indicate restrictive or obstructive disorders

49.

CBC

count and characteristics of formed elemets

50.

Hemoglobin

amount of hemoglobin

51.

Glycosylated hemoglobin (HBA1c)

amount of glucose bound to hemoglobin; blood glucose levels over months

52.

hematocrit (HCT)

percentage of erythrocytes in a specific volume of blood

53.

white blood cell differentiation count

assess proportions of leukocytes, "differential count"

54.

Bone marrow aspiration

used to confirm abnormalities related to production of red blood cells; megaloblastic anemia, leukemia

55.

Blood culture and sensitivity

bacteremia or unknown infection

56.

blood blotting tests

evaluate clotting time or clotting factors

57.

Hemoglobin electrophoresis

detects abnormal hemoglobin

58.

Serum-ferritin levels

amount of iron storage

59.

Arterial blood gas (ABG)

acid-base balance, oxygen levels, serum pH, PO2, PCO2, SO2, carbon dioxide and oxygen content, bicarbonate, base excess or deficity

60.

Immunodiagnostic tests

serum antigen antibody tests

skin tests, scratch tests

61.

Chromosomal and genetic analysis

detect chromosome or genetic abnormalities

paternity testing or forensics

62.

Therapeutic drug monitoring

serum drug levels checked when narrow therapeutic range for drug, risk of toxicity, or severe renal/liver disease

potential drug interactions

63.

Atrophy

a decrease in size of cells, resulting in decreased tissue mass

64.

Hypertrophy

increase in cell size, resulting in enlarged tissue mass

65.

Hyperplasia

increase in cell number, resulting in enlarged tissue mass

66.

Metaplasia

one mature cell type replaced by another mature cell type

67.

Dysplasia

tissue in which cells vary in size and shape, large nuclei are frequently present, rate of mitosis increased

68.

Anaplasia

cells are undifferentiated with variable nuclear and cell structures and numerous mitotic figures

69.

Neoplasia

"new growth;" tumor; benign (non-spreading) or malignant (can spread/metastasize

70.

Ischemia

decreased oxygenated blood supply due to circulatory obstruction

71.

Hypoxia

decreased oxygen in cells or tissues

72.

Liquefaction necrosis

dead cells liquify due to cellular enzymes; ex. brain tissue

73.

Coagulative necrosis

cell proteins are denatured and cells retain some form for a time after death; ex. myocardial infarction; kidney

74.

Fat necrosis

fatty tissue broken down into fatty acids, causing inflammation; ex. mesentary

75.

Caseous necrosis

form of coagulation necrosis in which a thick, yellowish, "cheesy" substance forms; ex. tuberculosis

76.

Infarction

area of dead cells resulting from lack of oxygen; loss of tissue function in the area

77.

Gangrene

area of necrotic tissue associated with a lack of blood supply followed by invasion of bacteria